MYLAN-AMLODIPINE/ATORVASTATIN
MYLAN PHARMACEUTICALS ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MYLAN-AMLODIPINE/ATORVASTATIN in Canada?
A shortage of MYLAN-AMLODIPINE/ATORVASTATIN 80MG 5MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 14, 2026), but it has not started yet.
Why is MYLAN-AMLODIPINE/ATORVASTATIN not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will MYLAN-AMLODIPINE/ATORVASTATIN be available again?
The estimated resolution date (September 21, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-09-21
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02362783
Strength
80MG 5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ATORVASTATIN AMLODIPINE
Tier
Unrated
Last Updated
2026-09-14
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from MYLAN PHARMACEUTICALS ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02385473
333MG · DIN 02293269
40MG · DIN 02257963
10MG · DIN 02257955
DIN 02388138
DIN 02388146
50MG · DIN 02468549
2G · DIN 02407310
1G · DIN 02407302
12.5MG · DIN 02554631
100MG · DIN 02247244
25MG · DIN 02247243